Sc Xii Management LLC Natera, Inc. Transaction History

Sc Xii Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$26.36 - $49.86 $20.4 Million - $38.6 Million	-774,446 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$17.27 - $40.17 $26.7 Million - $62.2 Million	-1,548,892 Reduced 66.67%	774,446 $23.1 Million
Q4 2019 Feb 14, 2020	SELL	$32.1 - $40.4 $99.4 Million - $125 Million	-3,097,784 Reduced 57.14%	2,323,338 $78.3 Million
Q3 2019 Nov 14, 2019	SELL	$25.38 - $34.89 $59 Million - $81.1 Million	-2,323,338 Reduced 30.0%	5,421,122 $178 Million
Q3 2017 Nov 13, 2017	BUY	$8.02 - $13.33 $62.1 Million - $103 Million	7,744,460	7,744,460 $99.8 Million

527

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $15.7B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Sc Xii Management LLC, based on Form 13F filings with the SEC.

Stay updated on Sc Xii Management LLC with notifications on news.